Private equity firm Arsenal Capital Partners’ portfolio company WIRB-Copernicus Group has acquired Research Dataware, the software developer and provider of IRBNet, an application supporting institutional review boards (IRBs).
Based in Massachusetts, Research Dataware enables research organisations to comply with regulations and efficiently manage the process and documentation complexities required by federal and state regulations.
Launched in 2005 as a web-based, software-as-a-service (SaaS) application, IRBNet is now the most widely used electronic solution for managing the research compliance practices of institutions that conduct clinical research. IRBNet has more than 90,000 users within 1,700 hospitals, research sites, defence department facilities, universities and medical schools.
In addition to IRBNet, Research Dataware’s proprietary web-based software solutions support institutional animal care and use committees, institutional biosafety committees and institutional conflict-of-interests committees.
Arsenal has acquired Research Dataware as an addition to The WIRB-Copernicus Group, an Arsenal portfolio company. The WIRB-Copernicus Group was formed by the acquisition of Western IRB in February 2012 and of the Copernicus Group IRB in June 2012. The WIRB-Copernicus Group provides ethical and regulatory services that support the clinical research enterprise.
"We are delighted to welcome the extraordinary professionals of Research Dataware into Arsenal and into The WIRB-Copernicus Group," says Donald A Deieso, operating partner and co-head of Arsenal’s healthcare group and executive chairman of The WIRB-Copernicus Group. "IRBNet is a valuable extension of The WIRB-Copernicus Group platform for delivering the gold-standard of IRB review and consulting services to our institutional clients that include hospitals, universities and medical schools.”
"We are proud to partner with Arsenal Capital and The WIRB-Copernicus Group; both organisations bring deep industry experience and a transformational approach to the ethical review process," says Jeremy Katz, president and founder of Research Dataware. "We share their mission to enable institutions to conduct high-quality, efficient, ethical research, and look forward to our accelerated growth in academic medical centres and hospitals."
